OCUL in the 13F filings
Ocular Therapeutix Inc · CUSIP 67576A100
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 18 May 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 29
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 5 listed it in both
- Shares listed
- 64,439,822
- combined, among listed positions
- Reported value
- $561m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 19 buyers (opened or added shares) and 13 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +5,267,552.
Managers listing OCUL in Q1 2026
29 of 29 holders
Largest increases and reductions, by shares
Increases
- T. Rowe Price Associates Incexisting position · 5,897,149 shares now+5,725,625
- Point72 Asset Management LPexisting position · 5,534,985 shares now+4,518,737
- Balyasny Asset Management LLCexisting position · 2,692,622 shares now+1,929,063
- Two Sigma Investments LPexisting position · 1,830,159 shares now+1,449,446
- Fidelity (FMR LLC)existing position · 32,653,764 shares now+868,159
Reductions
- Janus Henderson Group Ltdexisting position · 68,500 shares now-4,160,702
- Millennium Management LLCexisting position · 34,006 shares now-3,173,875
- Citadel Advisors LLCexisting position · 635,922 shares now-1,839,927
- D. E. Shaw & Co.existing position · 218,478 shares now-935,432
- Marshall Wace LLPexisting position · 740,803 shares now-636,400
New positions and exits
New (3)
Exited (4)
- Voloridge Investment Management LLCwas $9.9m
- Caxton Associates LLPwas $218k
- Schonfeld Strategic Advisors LLCwas $150k
- Acadian Asset Management LLCwas $32k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2014 | 1 | $14m | n.a. | n.a. |
| Q4 2014 | 1 | $22m | n.a. | n.a. |
| Q1 2015 | 2 | $121m | n.a. | n.a. |
| Q2 2015 | 3 | $107m | n.a. | n.a. |
| Q3 2015 | 3 | $72m | n.a. | n.a. |
| Q4 2015 | 2 | $46m | n.a. | n.a. |
| Q1 2016 | 2 | $47m | n.a. | n.a. |
| Q2 2016 | 1 | $97k | n.a. | n.a. |
| Q3 2016 | 1 | $143k | n.a. | n.a. |
| Q4 2016 | 1 | $1.9m | n.a. | n.a. |
| Q1 2017 | 1 | $1.6m | n.a. | n.a. |
| Q2 2020 | 1 | $289k | n.a. | n.a. |
| Q4 2020 | 2 | $41m | n.a. | n.a. |
| Q1 2021 | 2 | $39m | n.a. | n.a. |
| Q2 2021 | 1 | $17m | n.a. | n.a. |
| Q3 2021 | 1 | $11m | n.a. | n.a. |
| Q1 2023 | 1 | $344k | n.a. | n.a. |
| Q1 2024 | 1 | $9.9m | 1 | 0 |
| Q2 2024 | 1 | $19m | 1 | 0 |
| Q3 2024 | 3 | $36m | 2 | 1 |
| Q4 2024 | 3 | $45m | 3 | 0 |
| Q1 2025 | 2 | $14m | 0 | 2 |
| Q2 2025 | 1 | $9.9m | 0 | 1 |
| Q3 2025 | 3 | $86m | 3 | 0 |
| Q4 2025 | 5 | $88m | 22 | 11 |
| Q1 2026 | 4 | $69m | 19 | 13 |
| Q2 2026 | 1 | $16m | 10 | 20 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
OCUL and LLY →OCUL and JNJ →OCUL and VRTX →Choose a stock to compare with OCUL →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own OCUL, latest filings →Back to the 13F Explorer →